GLP-2 in particular is implicated in maintenance of the intestinal mucosal integrity and barrier function by its effects on epithelial permeability [10], indicating the potential for therapeutic targeting of GCG and GLP in colonic diseases. The gene discussed is GCG; the disease is colonic disorder.